These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 28144971)
1. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. Lee HY; Walsh SA; Creamer D Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971 [TBL] [Abstract][Full Text] [Related]
2. Complications of Stevens-Johnson syndrome beyond the eye and skin. Saeed H; Mantagos IS; Chodosh J Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527 [TBL] [Abstract][Full Text] [Related]
3. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701 [TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications. Ueta M Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311 [No Abstract] [Full Text] [Related]
7. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. De Rojas MV; Dart JK; Saw VP Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145 [TBL] [Abstract][Full Text] [Related]
8. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related]
9. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094 [TBL] [Abstract][Full Text] [Related]
10. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa]. Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020 [TBL] [Abstract][Full Text] [Related]
12. [Ocular involvement in Stevens-Johnson syndrome: treatment with amniotic membrane transplantation in the acute phase]. Kardaun SH; Huei Liem K; Stoutenbeek R Ned Tijdschr Geneeskd; 2017; 161():D1739. PubMed ID: 29171370 [TBL] [Abstract][Full Text] [Related]
13. Ocular manifestations of Stevens-Johnson syndrome and their management. Saeed HN; Chodosh J Curr Opin Ophthalmol; 2016 Nov; 27(6):522-529. PubMed ID: 27585215 [TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor re: 'Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up'. Olteanu C; Shear N; Hashimoto R; Dodiuk-Gad RP Br J Dermatol; 2017 Nov; 177(5):1461-1462. PubMed ID: 28626892 [No Abstract] [Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY; J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971 [TBL] [Abstract][Full Text] [Related]
17. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432 [TBL] [Abstract][Full Text] [Related]
18. Physical and Psychological Recovery Following Toxic Epidermal Necrolysis: A Patient Survey. DeNiro KL; Honari S; Hippe DS; Dai A; Pham TN; Caceres M; Mandell SP; Duong PQ; McMullen KA; Gibran NS J Burn Care Res; 2021 Nov; 42(6):1227-1231. PubMed ID: 34105730 [TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
20. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JK; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KM; Wong GA; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH Br J Dermatol; 2016 Jun; 174(6):1194-227. PubMed ID: 27317286 [No Abstract] [Full Text] [Related] [Next] [New Search]